Neurocrine Biosciences

Last updated: May 01, 2024

Kevin C. Gorman, CEO
Kevin C. Gorman, CEO
Country: USA | Funding: $260M (+)

Website: https://www.neurocrine.com

Neurocrine Biosciences engages in the discovery and development of drugs for the treatment of neurological and endocrine-related diseases.